United States· US:0078-0698_8903ad5f-436d-46ae-9f34-8415cbb8d993
RYDAPT
A medicinal product containing rydapt, registered in United States by Novartis Pharmaceuticals Corporation.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- RYDAPT
- Manufacturer
- Novartis Pharmaceuticals Corporation
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 12, 2026
Packs & prices · 2
- ndc1100780698194 CARTON in 1 CARTON (0078-0698-19) / 14 BLISTER PACK in 1 CARTON (0078-0698-51) / 2 CAPSULE, LIQUID FILLED in 1 BLISTER PACK (0078-0698-02)
- ndc1100780698992 CARTON in 1 CARTON (0078-0698-99) / 14 BLISTER PACK in 1 CARTON (0078-0698-51) / 2 CAPSULE, LIQUID FILLED in 1 BLISTER PACK (0078-0698-02)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Rydapt in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandRydaptNovartis Europharm Limited
- SwitzerlandRydapt 25 mg, WeichkapselnNovartis Pharma Schweiz AG
- CzechiaRYDAPTNovartis Europharm Limited, Dublin
- IrelandRydapt 25 mg soft capsulesNovartis Europharm Limited
- IcelandRydaptNovartis Europharm Limited*
- NorwayRydaptNovartis Europharm Limited (1)
- PolandRydaptNovartis Europharm Limited
- SwedenRydapt 25 mg Kapsel, mjukNovartis Europharm Limited
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Rydapt
- Liechtenstein · Rydapt
- Norway · Rydapt
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b61be71b-5de5-46dd-a101-ebce715fbfbd GET /v1/drugs/b61be71b-5de5-46dd-a101-ebce715fbfbd?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"livertox": {
"summary": null,
"livertox_id": null,
"hepatotoxicity_score": 5
},
"productid": "0078-0698_8903ad5f-436d-46ae-9f34-8415cbb8d993",
"productndc": "0078-0698",
"dosage_form": "CAPSULE, LIQUID FILLED",
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "MIDOSTAURIN",
"proprietary_name": "RYDAPT",
"active_ingred_unit": "mg/1",
"application_number": "NDA207997",
"marketing_category": "NDA",
"nonproprietary_name": "RYDAPT",
"start_marketing_date": "20170428",
"active_numerator_strength": "25"
}See everything about rydapt.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.